| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| John Allonce, Sikandar Khan, Brian Pulfor. Atypical Presentation of Ziprasidone-Induced Neuroleptic Malignant Syndrome: A Case Report. Journal of investigative medicine high impact case reports. vol 12. 2024-07-24. PMID:39044558. |
neuroleptic malignant syndrome (nms) is a severe adverse reaction associated with neuroleptic or antipsychotic drugs. |
2024-07-24 |
2024-07-26 |
Not clear |
| Nikita H Seth, Raghumahanti Raghuveer, Moh'd Irshad Quresh. Integrating Physiotherapy in Neuroleptic Malignant Syndrome Management: A Case Report. Cureus. vol 16. issue 6. 2024-07-23. PMID:39040743. |
neuroleptic malignant syndrome (nms) is a rare but potentially fatal condition characterized by hyperthermia, autonomic dysregulation, altered mental status, and muscular rigidity. |
2024-07-23 |
2024-07-25 |
Not clear |
| Shunsuke Nakamura, Atsuyoshi Iida, Kohei Tsukahara, Hiromichi Nait. Successful Diagnosis of Neuroleptic Malignant Syndrome in an Unconscious Patient Using Amplitude-Integrated Electroencephalography: A Case Report. Cureus. vol 16. issue 6. 2024-07-10. PMID:38978900. |
neuroleptic malignant syndrome (nms) is a rare but life-threatening medical condition often characterized by altered consciousness and clinical features resembling seizures. |
2024-07-10 |
2024-07-12 |
Not clear |
| Hitomi Komoriya, Konoka Nomura, Toshinori Shirata, Tadahiro Kobayashi, Masaki Nakane, Keisuke Noto, Ryota Kobayashi, Akihito Suzuk. A fatal case of fulminant neuroleptic malignant syndrome: A case report. PCN reports : psychiatry and clinical neurosciences. vol 2. issue 1. 2024-06-13. PMID:38868402. |
neuroleptic malignant syndrome (nms), a rare but potentially life-threatening adverse reaction to treatment with antipsychotic drugs, is characterized by hyperthermia, muscle rigidity, impaired consciousness, and autonomic disturbances. |
2024-06-13 |
2024-06-15 |
Not clear |
| Seyedehnasibeh Sadati, Forouzan Elyasi, Zahra Shyasi, Behzad Rouhanizade. Long prodromal symptoms of neuroleptic malignant syndrome in patient with intellectual developmental disorder-A case report. Neuropsychopharmacology reports. 2024-06-04. PMID:38832410. |
neuroleptic malignant syndrome (nms) is a rare and potentially life-threatening condition that may arise at any point during treatment and is often associated with adverse reactions to dopamine-blocking agents. |
2024-06-04 |
2024-06-06 |
Not clear |
| Sacha Celik, Veronica de Gennaro, João C-P-Silva, Kevin Swierkosz-Lenart, Armin von Gunte. Successful Treatment of Both Refractory Neuroleptic Malignant Syndrome and Subsequent Catatonia With Electroconvulsive Therapy in a Patient With Suspected Kufs Disease. The journal of ECT. 2024-06-03. PMID:38830195. |
we describe a patient suffering from probable kufs disease who developed a neuroleptic malignant syndrome (nms) after use of an antipsychotic agent over some weeks during hospitalization due to neuropsychiatric symptoms. |
2024-06-03 |
2024-06-06 |
Not clear |
| Waleed M Sweile. Neuroleptic malignant syndrome and serotonin syndrome: a comparative bibliometric analysis. Orphanet journal of rare diseases. vol 19. issue 1. 2024-06-02. PMID:38825678. |
this study aimed to analyze and map scientific literature on neuroleptic malignant syndrome (nms) and serotonin syndrome (ss) from prestigious, internationally indexed journals. |
2024-06-02 |
2024-06-05 |
Not clear |
| Jordan P Fader, Madison Walker Evans, Austin M Lundgren, Trenton B Sigmund, Taylor J Alle. Haloperidol-Induced Neuroleptic Malignant Syndrome: A Case Report. Cureus. vol 16. issue 3. 2024-05-01. PMID:38686249. |
neuroleptic malignant syndrome (nms) is a severe reaction to antipsychotic medications characterized by fever, muscle rigidity, altered mental status, and autonomic dysfunction. |
2024-05-01 |
2024-05-03 |
Not clear |
| Eduardo Macedo, Filipa Rodrigues, Ana Rita Marques, Luís Ribeiro, Pedro Silveir. Neuroleptic Malignant Syndrome: An Intensive Care Unit Case of Exceptionally High Creatinine Kinase and Myoglobin Levels. Cureus. vol 16. issue 3. 2024-04-17. PMID:38628997. |
neuroleptic malignant syndrome (nms) is a rare, life-threatening neurologic emergency known to be related to the administration or sudden withdrawal of dopaminergic medications. |
2024-04-17 |
2024-04-19 |
Not clear |
| Zong-Jun Te. A rare case of prochlorperazine-induced neuroleptic malignant syndrome. The American journal of emergency medicine. 2024-04-04. PMID:38575461. |
neuroleptic malignant syndrome (nms) is a rare yet severe condition typically associated with antipsychotic medications. |
2024-04-04 |
2024-04-07 |
Not clear |
| Nicole Kraaijvanger, Tim Mielo. Neuroleptic malignant syndrome after overdose of haloperidol - A case report. Toxicology reports. vol 12. 2024-04-01. PMID:38560509. |
the neuroleptic malignant syndrome (nms), alternatively referred to as the antipsychotic malignant syndrome, is a potentially fatal condition that is infrequently observed and is linked to the administration of antipsychotic medications. |
2024-04-01 |
2024-04-04 |
Not clear |
| b' Onur G\\xc3\\xb6k\\xc3\\xa7en, Merve Akku\\xc5\\x9. Neuroleptic Malignant Syndrome Concurrent with COVID-19 Infection: A Case Report. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 1. 2024-04-01. PMID:38556939.' |
neuroleptic malignant syndrome (nms), which most often occurs after the use of antipsychotics, is a rare but life-threatening condition. |
2024-04-01 |
2024-04-03 |
Not clear |
| Anıl Alp, Melike Karaçam Doğan, Elçin Özçelik Eroğlu, Mevhibe İrem Yildiz, Şeref Can Gürel, Suzan Öze. Transient Fever Response After ECT in a Patient with Catatonic Schizophrenia: A Case Report. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 1. 2024-04-01. PMID:38556940. |
fever; in addition to general medical conditions such as infection, malignancy, connective tissue diseases, drug treatments, malignant hyperthermia, convulsions, it can also occur due to conditions such as neuroleptic malignant syndrome (nms), serotonin syndrome, catatonia, malignant catatonia, which are frequently encountered in psychiatry clinics. |
2024-04-01 |
2024-04-03 |
Not clear |
| Nora Vanegas-Arroyave, Stanley N Caroff, Leslie Citrome, Jovita Crasta, Roger S McIntyre, Jonathan M Meyer, Amita Patel, J Michael Smith, Khody Farahmand, Rachel Manahan, Leslie Lundt, Samantha A Cicer. An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders. CNS drugs. 2024-03-19. PMID:38502289. |
although rare, neuroleptic malignant syndrome (nms) is a potentially life-threatening consequence of drba exposure. |
2024-03-19 |
2024-03-23 |
Not clear |
| Simon Farrugia, Sarah Bonello, Yanika Gatt, Martin V Balza. Atypical Neuroleptic Malignant Syndrome With Type 2 Respiratory Failure Treated With Non-invasive Ventilation. Cureus. vol 16. issue 1. 2024-02-08. PMID:38327911. |
neuroleptic malignant syndrome (nms) is characterized by hyperthermia, severe rigidity, and autonomic instability that is life-threatening if not treated promptly by intensive supportive care. however, there have been numerous reports of "atypical nms" where the diagnostic criteria of nms are only partially satisfied. we present a case of an elderly male who presented with atypical nms secondary to antidopaminergic drug administration which precipitated acute respiratory failure. |
2024-02-08 |
2024-02-10 |
Not clear |
| Matthew Zabel, Rajeev Kandukur. Atypical neuroleptic malignant syndrome in an incarcerated patient: a demographic who may be at increased risk. BMJ case reports. vol 17. issue 2. 2024-02-06. PMID:38320820. |
atypical neuroleptic malignant syndrome (nms) was diagnosed after discrediting similar illnesses through clinical reasoning, laboratory and imaging studies. |
2024-02-06 |
2024-02-15 |
Not clear |
| Nissar Shaikh, Adnan Saadeddi. Parkinsonism-Hyperpyrexia Syndrome in a patient undergoing upper gastrointestinal surgery: A case report. Qatar medical journal. vol 2023. issue 4. 2024-01-11. PMID:38204562. |
it presents similarly to neuroleptic malignant syndrome (nms) and is characterized by severe rigidity, fever, autonomic instability, and altered mental status. |
2024-01-11 |
2024-01-13 |
Not clear |
| Jesus Ramirez-Bermudez, Miguel Restrepo-Martinez, Mariana Espinola-Nadurille, Victoria Martinez-Angeles, Juan Carlos Lopez-Hernandez, Laura E Hernandez-Vanegas, Francisco Martinez-Carrillo, Ramiro Ruiz-Garcia, Veronica Rivas-Alonso, Jose Flores-Rivera, Thomas A Polla. EXAMINING THE FEATURES OF NEUROLEPTIC MALIGNANT SYNDROME IN ANTI-NMDA RECEPTOR ENCEPHALITIS: A CASE-CONTROL STUDY. Journal of the Academy of Consultation-Liaison Psychiatry. 2023-12-27. PMID:38151160. |
symptomatic treatment with antipsychotics is common in early stages when psychiatric symptoms predominate, and their use has been associated with serious side effects including neuroleptic malignant syndrome (nms). |
2023-12-27 |
2023-12-30 |
Not clear |
| César Ricardo Coimbra de Matos, Eduarda Maria da Conceição Sério Pereira Beirão, Rafael Simões Neves, António José Assunção, Rui Moreira Marque. When the fever will not stop, stop the pills! A case report. Sao Paulo medical journal = Revista paulista de medicina. vol 142. issue 3. 2023-12-06. PMID:38055420. |
neuroleptic malignant syndrome (nms) is a neurologic emergency potentially fatal. |
2023-12-06 |
2023-12-10 |
Not clear |
| Keisuke Maeda, Toshihisa Ichiba, Kenichiro Kashiwa, Yuji Okazak. Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal. Cureus. vol 15. issue 10. 2023-12-01. PMID:38022067. |
neuroleptic malignant syndrome (nms) is a potentially fatal side effect that occurs in patients taking antipsychotics. |
2023-12-01 |
2023-12-07 |
Not clear |